Xella Health, PBC

Xella Health, PBC is a US-based healthcare company that specializes in women's health, addressing issues like fertility, hormonal imbalances, and reproductive cancer screening through advanced diagnostics and personalized care solutions. Founded in 2026 in San Francisco, US, Xella Health, PBC focuses on women's health, delivering specialized testing services. The company raised USD 3. 7 mn in a pre-seed funding round on January 13, 2026, with Health Innovations as a notable investor.

The total amount raised to date is USD 3. 7 mn. Xella Health provides advanced testing and care delivery services focused on women's health, specifically targeting fertility issues, chronic gynecologic symptoms, hormonal imbalances, perimenopause, and reproductive cancer screening. Their core offering includes a comprehensive screening service analyzing thousands of biomarkers through a female-specialized lens, offering risk categorization and triage for conditions like endometriosis and polycystic ovary syndrome (PCOS).

The use of AI-driven insights helps translate complex biological data into actionable care plans, supported by continuous telehealth services tailored to individual needs, designed for women of diverse ages and health conditions across the United States, with plans for geographical expansion. Xella Health operates a subscription-based revenue model alongside direct-to-consumer transactions, utilizing advanced technology for women's health diagnostics. Clients can access customized healthcare plans, including at-home testing kits and options for in-person lab visits. The structured transaction approach allows clients to receive tailored health insights and support from dedicated care teams, aligning pricing structures with the comprehensive nature of their service offerings.

In January 2026, Xella Health raised USD 3. 7 mn to develop a multi-modal AI platform that integrates wearable data, electronic medical record inputs, and patient-reported results for diabetes and hypertension. The company anticipates launching new products designed for early detection and proactive health management for women, with plans for expansion into new markets, aiming to reach a broader geographical audience after their initial launch in Spring 2026.